Beta Drugs Ltd vs Gufic Biosciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Beta Drugs Ltd is ₹ 1796 as of 15 Jun 10:59 . The P/E Ratio of Beta Drugs Ltd changed from 32.5 on March 2024 to 19.6 on March 2023 . This represents a CAGR of -9.62% over 5 yearsThe P/E Ratio of Gufic BioSciences Ltd changed from 33 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years The Market Cap of Beta Drugs Ltd changed from ₹ 1186 crore on March 2024 to ₹ 602.74 crore on March 2023 . This represents a CAGR of -12.66% over 5 yearsThe Market Cap of Gufic BioSciences Ltd changed from ₹ 2839 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years The revenue of Beta Drugs Ltd for the Mar '26 is ₹ 96.86 crore as compare to the Dec '25 revenue of ₹ 89.58 crore. This represent the growth of 8.13% The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 250.65 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the growth of 7.95% The ebitda of Beta Drugs Ltd for the Mar '26 is ₹ 20.57 crore as compare to the Dec '25 ebitda of ₹ 19.3 crore. This represent the growth of 6.58% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 46.04 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the growth of 36.33% The net profit of Beta Drugs Ltd changed from ₹ 8.95 crore to ₹ 9.05 crore over 6 quarters. This represents a CAGR of 0.74% The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 21.9 crore over 8 quarters. This represents a CAGR of 2.46% The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 years .

About Beta Drugs Ltd

Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

FAQs for the comparison of Beta Drugs Ltd and Gufic BioSciences Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or Gufic BioSciences Ltd?

Market cap of Beta Drugs Ltd is 1,795 Cr while Market cap of Gufic BioSciences Ltd is 3,723 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and Gufic BioSciences Ltd?

The stock performance of Beta Drugs Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and Gufic BioSciences Ltd?

As of June 15, 2026, the Beta Drugs Ltd stock price is INR ₹1771.2. On the other hand, Gufic BioSciences Ltd stock price is INR ₹371.3.

How do dividend payouts of Beta Drugs Ltd and Gufic BioSciences Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.